Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemia.

Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemia. Blood. 2008 Sep 01; 112(5):1876-85.

View in: PubMed

subject areas

Antigen-Presenting Cells
Antigens, Neoplasm
Cell Line
Cell Line, Tumor
Cytotoxicity, Immunologic
HLA-A Antigens
HLA-A2 Antigen
Humans
Immunotherapy, Adoptive
Interferon-gamma
K562 Cells
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
RNA, Messenger
RNA, Neoplasm
T-Lymphocytes, Cytotoxic

authors with profiles

VALENTINA HOYOS
CLIONA ROONEY
HELEN HESLOP